BSPED2022

02 November 2022

08:50-09:00Welcome and Introduction
Chair(s): Dinesh Giri, BSPED CME Officer (Bristol, UK)
Hall 1A
09:00-10:00CME Session 1
Chair(s): Dinesh Giri (Bristol, UK) & Georgina Williams (Cardiff, UK)
Hall 1A
09:00Endocrine approach of a patient with late effects
09:30Genetic approach to short stature
10:00-10:30CME Case Presentations 1
Chair(s): Dinesh Giri (Bristol, UK) & Georgina Williams (Cardiff, UK)
Hall 1A
10:15OC1.1Defects in QSOX2, a novel regulator of STAT5B nuclear import and transcriptional activity, lead to severe post-natal growth restriction
10:00OC1.2A rare case of short stature with high total Insulin Like Growth Factor 1 (IGF-1) and a novel pregnancy-associated plasma protein A2 (PAPPA2) gene mutation
10:30-11:00Break
Hall 1C & 1D
11:00-12:00CME Session 2
Chair(s): Dinesh Giri (Bristol, UK) & Elspeth Ferguson (Sheffield, UK)
Hall 1A
11:00Neonatal Diabetes
11:30An approach to hypo/hypercalcemia
12:00-12:30CME Case Presentations 2
Chair(s): Dinesh Giri (Bristol, UK) & Elspeth Ferguson (Sheffield, UK)
Hall 1A
12:00OC2.1Coeliac disease presenting with anti-OPG antibody mediated childhood osteoporosis and response to bisphosphonate therapy
12:15OC2.2The missing segment from the age of enlightenment
12:30-12:40CSAC Trainee Representative Update
Chair(s): Katherine Hawton (Bristol, UK) & Rachel Boal (Newcastle, UK)
Hall 1A
12:40-13:30Lunch
Hall 1C & 1D
13:30-14:30CME Session 3
Chair(s): Dinesh Giri (Bristol, UK) & Harriet Gunn (London, UK)
Hall 1A
13:30Estrogen replacement in girls with Primary ovarian insufficiency
14:00Approach to hypogonadism in adolescent boys
14:30-15:00CME Case Presentations 3
Chair(s): Dinesh Giri (Bristol, UK) & Harriet Gunn (London, UK)
Hall 1A
14:30OC3.2Two cases on the Carney Complex spectrum secondary to PRKACA/PRKAR1A variants presenting with Cushing Syndrome in childhood
14:45OC3.1A rare form of ovotesticular difference of sex development (DSD) in combination with severe early-onset obesity due to MC4R mutation: Clinical features and diagnostic challenges
15:00-15:30Break
Hall 1C & 1D
15:30-16:00CME Session 4
Chair(s): Dinesh Giri (Bristol, UK) & Rachel Boal (Newcastle, UK)
Hall 1A
15:30An approach to dynamic stimulation tests with challenges and pitfalls
16:00-16:30CME Case Presentations 4
Chair(s): Dinesh Giri (Bristol, UK) & Rachel Boal (Newcastle, UK)
Hall 1A
16:00OC4.1Pseudohypoaldosteronism case series
16:15OC4.2Treatment-induced neuropathy of diabetes: A case report
16:30-16:45CME Officer's Update & Conclusion
Chair(s): Dinesh Giri (Bristol, UK)
Hall 1A
17:00-18:00Industry Sponsored Satellite Symposium
For more information please refer to the Industry Sponsored Programme
Hall 1A
17:00-18:00Industry Sponsored Satellite Symposium
For more information please refer to the Industry Sponsored Programme
Hall 1B
18:00-19:00Welcome Reception
Hall 1C & 1D

03 November 2022

08:00-08:45Industry Sponsored Satellite Symposium
For more information please refer to the Industry Sponsored Programme
Hall 1A
08:45-09:00Break
Hall 1C & 1D
09:00-09:10Welcome and Introduction
Chair(s): Tabitha Randell, Nottingham (BSPED President) Senthil Senniappan, Liverpool (POC Chair) Noina Abid, Belfast (Local Convenor)
Hall 1A
09:10-10:40Endocrine Oral Communications 1
Chair(s): Charlotte Elder (Sheffield, UK) & Evelien Gevers (London, UK)
Hall 1A
09:10OC5.1Can lymphocyte subsets and B cell cytokines predict clinical response to Rituximab in paediatric Graves’ disease?
09:20OC5.2Central Delayed puberty in Adolescence: Differentiating the phenotypes of Congenital Hypogonadotropic Hypogonadism and Self-Limited Delayed Puberty.
09:30OC5.3UK Protocol for Induction of Puberty with Gonadotropins in Males with Hypogonadotropic Hypogonadism
09:40OC5.4Greater Postnatal Adiposity Gain Following Inadequate Fetal Growth in The Manchester BabyGRO Study
09:50OC5.5The lack of genotype:phenotype correlations in rare causes of primary adrenal insufficiency highlights the need for genetic testing
10:00OC5.6Prevalence of overweight and obesity in children with bone fragility and its correlation with disease severity and fracture rate
10:10OC5.7Salivary Cortisol and Cortisone in Healthy Children and Young People
10:20OC5.8SGPL1 deficiency impairs Leydig cell steroidogenesis and should be considered in 46XY individuals with DSD and adrenal insufficiency
10:30OC5.9Evaluation Of A Low Postnatal Hypoglycaemia Threshold
09:10-10:40Diabetes and Covid Symposium
Chair(s): Tony Hulse (London, UK) & Rachel Besser (Oxford, UK)
Hall 1B
09:10Introduction and the South East Thames Study
09:20‘DIMPLES’: Children presenting with diabetes and diabetic ketoacidosis to Emergency Departments during the COVID-19 pandemic in the UK and Ireland: a multicentre retrospective observational study
09:40‘DIMPLES’: the Irish dimension
09:50‘Proving Causation?’: antibody studies in Covid related Diabetes
10:00Obesity and Type 2 diabetes and Covid
10:15'What does all this mean?’ A panel discussion and Q&A session including Dr. Colin Dayan and chaired by Dr.Rachel Besser
09:10-10:40Endocrine Nurses' Business Meeting
Chair(s): Lee Martin (London, UK) & Angela McCormick (Belfast, UK)
Meeting Room 1
10:40-11:10Break
Hall 1C & 1D
11:10-12:10Endocrine Symposium 1
Chair(s): Renuka Dias (Birmingham, UK) & Pooja Sachdev (Nottingham, UK)
Hall 1A
11:10Congenital Imprinting Disorders
11:40Consensus Guidelines for the management of Grave's diesease
11:10-12:10Diabetes Symposium 2
Chair(s): Anuja Natarajan (Doncaster, UK) & Noina Abid (Belfast, Northern Ireland)
Hall 1B
11:10Impact of Diabetes Ketoacidosis on glycaemic control
11:40The big fat question - lipids and glycaemia
12:10-12:40Endocrine Oral Communications 2
Chair(s): Christina Wei (London, UK) & Catherine Peters (London, UK)
Hall 1A
12:10OC6.1Pubertal staging examinations: A national survey of current practice in consent and chaperone use
12:16OC6.2The Arginine-nitric-oxide Pathway Links Suboptimal Fetal Growth to Higher Childhood Systolic Blood Pressure in The Manchester BabyGRO Study
12:22OC6.3Use of 24 weekly Decapeptyl SR in Central Precocious Puberty is Well-Tolerated and Efficacious – A Two Centre Study
12:28OC6.4A Collaborative Community based Approach in providing Support for Children and Young People with Severe Obesity
12:34OC6.5Bone Mineralisation as Assessed by Bone Health Index in Children with Congenital Adrenal Hyperplasia
12:10-12:40Diabetes Oral Communications 1
Chair(s): Melanie Kershaw (Birmingham, UK) & Fiona Campbell (Leeds, UK)
Hall 1B
12:10OC7.1Comparison of outcomes of the hybrid closed loop therapy with the conventional insulin pump in the first year after pump initiation
12:16OC7.2Self-collection of capillary blood samples at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitus
12:22OC7.5Monogenic obesity is probably not so rare - experience from a large tier 3 paediatric weight management service
12:28OC7.4Type A insulin resistance syndrome presenting with PCOS features and an unusual pattern of diabetes in a 10-year-old female
12:34OC7.3Hypogonadism and pubertal disorders in Wolfram Syndrome
12:40-13:10Industry Sponsored Expert Insights Session
For more information please refer to the Industry Sponsored Programme
Hall 1A
12:40-13:10Industry Sponsored Expert Insights Session
For more information please refer to the Industry Sponsored Programme
Hall 1B
13:10-14:10Lunch and Poster Tours
Hall 1C & 1D
14:10-14:40Awards Session - James M Tanner Award
Chair(s): Tabitha Randell (Nottingham, UK)
Hall 1A
14:10New abstract
14:40-15:40Diabetes Symposium 3
Chair(s): Toby Candler (Bristol, UK) & Tabitha Randell (Nottingham, UK)
Hall 1B
14:40Screening for Type 1 Diabetes - the ELSA study
15:10Immunotherapy in diabetes - preservation of beta cells
14:40-15:40Endocrine Symposium 2
Chair(s): Shankar Kanumakala (Brighton, UK) & Senthil Senniappan (Liverpool, UK)
Hall 1A
14:40BSPED consensus guidelines: Emergency and peri-operative management of adrenal insufficiency in children and young people
15:10UK Consensus Guidelines for Hyperinsulinism Management
15:40-15:50Break
Hall 1C & 1D
15:50-16:50Personal Practice Session
Chair(s): Ved Bhushan Arya (London, UK) & Bindu Avatapalle (Cardiff, UK)
Hall 1B
15:50Long acting growth hormone
16:20Structured education programme for Type 1 Diabetes in Northern Ireland
15:50-16:20Endocrine Oral Communications 3
Chair(s): Ritika Kapoor (London, UK) & Tim Cheetham (Newcastle, UK)
Hall 1A
15:50OC8.1Do we need earlier thyroid surveillance amongst PTEN patients in the UK?
15:56OC8.2Endocrine Effects of MEK and BRAF Inhibitor Therapy in Paediatric Patients: A Tertiary Centre Experience
16:02OC8.3Characterisation of the first heterozygous missense HMGA2 variant helps delineate the crucial functional roles of a novel growth gene
16:08OC8.4A national survey of bone-endocrine monitoring in Duchenne muscular dystrophy and the patients’ experience
16:14OC8.5Contrast media-induced hypothyroidism
17:00-18:00AGM (BSPED members only)
Hall 1A
19:30-00:00Conference Dinner
Belfast City Hall

04 November 2022

09:30-11:00Diabetes Symposium 4
Chair(s): Nicola Bridges (London, UK) & Louise Denvir (Nottingham, UK)
Hall 1A
09:30Interpreting continuous glucose monitoring
10:00Interpreting close loop pump downloads
10:30Developing an early stage treatment for diabetic retinopathy
09:30-11:00Nurses' Day for Endocrine Professionals (Endocrine Symposium 3)
Chair(s): Lee Martin (London, UK) & Jackie McNaboe (Belfast, UK)
Hall 1B
09:30CAH & Adolescent gynaecology – an MDT perspective
10:30CAH and adolescence - a parent's perspective
11:00-11:30Break
Hall 1C & 1D
11:30-13:00Diabetes Oral Communications 2
Chair(s): Mark Burns (Middleborough, UK) & Suma Uday (Birmingham, UK)
Hall 1A
11:30OC9.1Access and use of new technologies in diabetes care in patients that need an Interpreter compared to those that do not
11:40OC9.2Audit of Management of Diabetic Ketoacidosis in Children at the Noah's Ark Children's Hospital for Wales
11:50OC9.3Diabetes and obesity in Down Syndrome across the lifespan: a retrospective cohort study using UK electronic health records
12:00OC9.4Do the UK’s commercially available real-time continuous glucose monitoring devices have robust accuracy data for paediatrics?
12:10OC9.5Raising Awareness of the Importance of Preconception Counselling in Young People with Diabetes
12:20OC9.6A review of patient outcomes and responses to weight management strategies used by Complications from Excess Weight service, a new paediatric, hospital-based weight management service
12:30OC9.7Liraglutide for the treatment of severe obesity in children: early experiences from a tier 3 paediatric weight management service
12:40OC9.8Cyclic improvement of a structured education programme teaching dynamic glucose management strategies in children and young people with type 1 diabetes using Continuous Glucose Monitoring
11:30-12:30Nurses' Day for Endocrine Professionals (Oral Communications 4)
Chair(s): Lee Martin (London, UK) & Jackie McNaboe (Belfast, UK)
Hall 1B
11:30OC10.1Hormone Replacement Therapy in Paediatric Turner Syndrome – Evaluation of Current Practice in a Dedicated Paediatric Turner Clinic and Subsequent Development of Patient Resources
11:40OC10.2Patient and parent experiences with oral hydrocortisone formulations for adrenal insufficiency
11:50OC10.4Increasing Patient Adherence and reducing Drug Wastage: impact of a Personalised Patient Support Programme integrated with a digital connect ecosystem
12:00OC10.5Factors affecting the hypoglycaemic response in the Insulin Tolerance Test in paediatric patients
12:10OC10.6A comparative study observing the association between Graves’ disease and the Covid-19 pandemic in children
12:20OC10.3Development and testing of a novel ‘GrowthMonitor’ Smartphone App for growth monitoring and the detection of growth disorders
12:30-13:00Presentations from Previous Award Winners
Chair(s): Li Chan (London, UK) & Nadia Amin (Leeds, UK)
Hall 1B
12:30Bone health in Type 1 Diabetes: The Key Determinants of Skeletal Fragility and the Role of Metformin
13:00-13:45Lunch and Poster Tours
Hall 1C & 1D
13:45-14:15Industry Sponsored Expert Insights Session
For more information please refer to the Industry Sponsored Programme
Hall 1A
14:15-15:45Diabetes Symposium 5
Chair(s): David McGregor (Devon, UK) & Zainaba Mohamed (Birmingham, UK)
Hall 1A
14:15Conflict & Collaboration in Diabetes Management
14:45Diabetes in toddlers - practicalities and challenges
15:15How to create and adapt exercise plans when using Continuous Glucose Monitoring (CGM) and Automated Insulin Delivery Systems (AID) with type 1 diabetes
14:15-15:45Nurses' Day for Endocrine Professionals (Endocrine Symposium 4)
Chair(s): Martha Ford-Adams (London, UK) & Mars Skae (Manchester, UK)
Hall 1B
14:15Immune dysregulation driving future risk of disease in children with obesity
14:45Non-alcoholic fatty liver disease
15:15Paediatric Endocrinology in Art
15:45-16:00BSPED 2022 Awards Session
Chair(s): Senthil Senniappan (Liverpool, UK) & Nadia Amin (Leeds, UK)
Hall 1A
16:00-16:15Close of Meeting
Chair(s): Senthil Senniappan, POC Chair (Liverpool, UK)
Hall 1A